UK Heart Failure With Preserved Ejection Fraction

计划入组 10,000 人 · 首次发布于 2022 年 7 月 1 日

Copenhagen Heart Failure with Preserved Ejection Fraction

计划入组 5,000 人 · 首次发布于 2024 年 11 月 12 日

Characterization of Heart Failure With Preserved Ejection Fraction

计划入组 500 人 · 首次发布于 2017 年 6 月 23 日

Tovinontrine

C₂₁H₂₆N₆O₂

heart regeneration therapy (congestive heart failure)

Heart Failure(River Biomedics)

BERLIN HEART, INC.

United States

KEYSTONE HEART LTD

Israel

Heart Metabolics Ltd.

Ireland

Vasa Therapeutics Receives FDA IND Clearance for VS-041 in Heart Failure with Preserved Ejection Fraction

SPIRIT-HF Trial Shows No Benefit and Safety Concerns for Spironolactone in Heart Failure with Preserved Ejection Fraction

Semaglutide Shows Promise for Obesity-Related Heart Failure with Preserved Ejection Fraction